The FDA Finally Stopped Demanding Impossible Evidence From Dying Children
Demanding randomized controlled trials from populations of 400 scattered patients was never science. The FDA's Plausible Mechanism Framework finally matches the regulatory toolkit to the biological reality of ultra-rare disease, and the patients who benefit have zero time for debate.
By Kai Brighton · 3 min read